Hubei Jumpcan Pharmaceutical Co Ltd (600566) — Cash Flow-to-Debt Ratio
Hubei Jumpcan Pharmaceutical Co Ltd (600566) has a Cash Flow-to-Debt Ratio of -0.09x as of September 2025, meaning its operating cash flow of CN¥-243.75 Million could theoretically repay 0% of its total liabilities (CN¥2.68 Billion) in one year. See Hubei Jumpcan Pharmaceutical Co Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hubei Jumpcan Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2000–2025)
Historical debt coverage capacity for Hubei Jumpcan Pharmaceutical Co Ltd across 26 annual periods. For the full cash flow conversion analysis, see 600566 cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Hubei Jumpcan Pharmaceutical Co Ltd (2000–2025)
Year-by-year debt coverage analysis for Hubei Jumpcan Pharmaceutical Co Ltd. Check Hubei Jumpcan Pharmaceutical Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.39x | CN¥1.20 Billion | CN¥3.07 Billion | ▼ -33.0% |
| 2024 | 0.58x | CN¥2.18 Billion | CN¥3.73 Billion | ▼ -19.6% |
| 2023 | 0.73x | CN¥3.46 Billion | CN¥4.77 Billion | ▲ +0.4% |
| 2022 | 0.72x | CN¥2.62 Billion | CN¥3.63 Billion | ▲ +14.4% |
| 2021 | 0.63x | CN¥1.89 Billion | CN¥3.00 Billion | ▼ -2.4% |
| 2020 | 0.65x | CN¥1.78 Billion | CN¥2.75 Billion | ▼ -22.8% |
| 2019 | 0.84x | CN¥2.15 Billion | CN¥2.56 Billion | ▲ +14.8% |
| 2018 | 0.73x | CN¥1.71 Billion | CN¥2.34 Billion | ▲ +38.9% |
| 2017 | 0.53x | CN¥1.19 Billion | CN¥2.26 Billion | ▼ -25.1% |
| 2016 | 0.70x | CN¥913.10 Million | CN¥1.30 Billion | ▼ -5.1% |
| 2015 | 0.74x | CN¥645.48 Million | CN¥872.59 Million | ▲ +27.7% |
| 2014 | 0.58x | CN¥616.11 Million | CN¥1.06 Billion | ▲ +73.9% |
| 2013 | 0.33x | CN¥287.16 Million | CN¥862.04 Million | ▲ +519.2% |
| 2012 | 0.05x | CN¥27.01 Million | CN¥502.07 Million | ▲ +5590.6% |
| 2011 | 0.00x | CN¥411.24K | CN¥435.00 Million | ▼ -99.4% |
| 2010 | 0.15x | CN¥51.13 Million | CN¥342.89 Million | ▲ +880.6% |
| 2009 | 0.02x | CN¥4.92 Million | CN¥323.37 Million | ▼ -78.7% |
| 2008 | 0.07x | CN¥23.05 Million | CN¥323.43 Million | ▼ -41.1% |
| 2007 | 0.12x | CN¥36.72 Million | CN¥303.49 Million | ▲ +757.6% |
| 2006 | 0.01x | CN¥4.24 Million | CN¥300.69 Million | ▼ -94.4% |
| 2005 | 0.25x | CN¥63.38 Million | CN¥251.96 Million | ▲ +249.3% |
| 2004 | -0.17x | CN¥-37.74 Million | CN¥223.98 Million | ▼ -1481.1% |
| 2003 | 0.01x | CN¥2.24 Million | CN¥183.92 Million | ▼ -91.8% |
| 2002 | 0.15x | CN¥22.00 Million | CN¥148.17 Million | ▲ +166.1% |
| 2001 | 0.06x | CN¥7.43 Million | CN¥133.08 Million | ▼ -80.4% |
| 2000 | 0.28x | CN¥23.73 Million | CN¥83.37 Million | — |